Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 73.07
-0.12 (-0.16%)
May 6, 2026, 3:00 PM CST
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 45.24 billion as of May 6, 2026. Its market cap has increased by 152.91% in one year.
Market Cap
45.24B
Enterprise Value
43.72B
Revenue
4.32B
Ranking
n/a
PE Ratio
15.30
Stock Price
73.07
Market Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 45.24B, an increase of 35.70%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 45.24B | 23.12% |
| Dec 31, 2025 | 36.74B | 178.10% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 64.92B |
| Pharmaron Beijing | 49.77B |
| Beijing Wantai Biological Pharmacy Enterprise | 49.69B |
| Asymchem Laboratories (Tianjin) | 44.23B |
| Shanghai Allist Pharmaceuticals | 41.67B |
| Hebei Changshan Biochemical Pharmaceutical | 38.01B |
| Shanghai RAAS Blood Products | 36.46B |
| Chongqing Zhifei Biological Products | 36.27B |